ConductCognition
  • Domains

    Tests

    • Processing speed43
    • Attention113
    • Working memory50
    • Executive function143
    • Episodic memory72
    • Response inhibition9
    • Social cognition75
    • Language42

    Most used

    Evidence

    1. Verbal Fluency TestGradeA
    2. Stroop Color-Word TestGradeA
    3. Trail Making TestGradeA
    4. N-Back TaskGradeA
    5. Go/No-Go TaskGradeA
    6. Digit Span TestGradeA
    7. Symbol Coding TestGradeA
    8. Verbal Learning TestGradeA
    REDTry it nowStroop Color-Word Test
    All 547 tests

    Browse by

    • Phone290
    • Tablet323
    • Untimed326
    • Up to 5 minutes69
    • Evidence grade A40
  • First studies

    Grade, length

    • Reaction Time StudyGradeA7 min
    • Pilot ScreeningGradeA15 min
    • Medication StudiesGradeA−26 min
    • Language-Minimized ScreeningGradeA−30 min

    Age groups

    • Older Adult Executive SpeedGradeA20 min
    • School-AgeGradeA−33 min

    Memory

    • At-Home MemoryGradeA26 min
    • Working Memory and LearningGradeA−19 min
    • Associative MemoryGradeB32 min
    • Working Memory CapacityGradeB34 min

    Language and perception

    • LanguageGradeA−33 min
    • Visual PerceptionGradeB27 min
    • Listening and Auditory ProcessingGradeB31 min

    Executive function and attention

    • Executive ControlGradeA18 min
    • Attention and ImpulsivityGradeA−26 min
    • Visual AttentionGradeB27 min
    • Creativity and Flexible ThinkingGradeB30 min
    • Reasoning and SpatialGradeB32 min

    Movement

    • Motor and AttentionGradeA−29 min
    • Motor LearningGradeB34 min

    Behavior, mood and choice

    • Food Choice and Self-ControlGradeA−29 min
    • Sleep and FatigueGradeB23 min
    • Social CognitionGradeB23 min
    • Impulsivity and Substance UseGradeB26 min
    • Emotion and MoodGradeB28 min
    • Decisions and RewardGradeB29 min
    All 26 batteries

    Find one

    Up to 15 minutes2Up to 30 minutes19Phone8
    Test order labBattery gradesHow batteries work
  • Use and evidence

    • Overview
    • Compare all 547 tests
    • Test-retest
    • Reliability and validity
    • Battery grades26
    • Download and cite

    Clinical trials

    • Overview
    • By condition25
    • By test101
    • Trial design benchmark
    • Cognitive outcomes, 2026

    Conditions

    Registered studies

    • Dementia and Alzheimer's1,673
    • Aging, frailty and exercise1,398
    • Depression and bipolar disorder1,247
    • Stroke1,233
    • Substance use and addiction895
    • Parkinson's disease892
    • Cancer760
    All 25 conditions
    16,361Registered studies name a cognitive test in an outcome measure11,688 name a test you can run hereExplore the studies
  • 1

    Build

    • Study design
    • Customize tests
    • Repeat visits
    • Study cost calculator
    2

    Recruit

    • Recruitment setup
    • Prolific
    • Sona Systems
    • CloudResearch Connect
    • Qualtrics
    3

    Run

    • Remote testing
    • Participant devices
    • Phone timing check
    • Offline edition
    4

    Results

    • Automated scoring
    • Test norms
    • Study Quality Monitor
    • Data export
    Platform overview

    Compliance

    • HIPAA-ready testing
    • US clinical research
    • Data Policy
    • Privacy Policy
    • Terms of Use
  • Research areas

    Tests used in each

    • Aging and dementia188
    • Decisions and reward105
    • Child development and education87
    • Language and bilingualism64
    • Social behavior62
    • Psychiatric groups35
    • Training and intervention28
    • Mood, anxiety and trauma25
    • Substance use and impulsivity25
    • Neurological and movement research19
    • Brain injury and concussion14
    • Sleep and fatigue14
    • ADHD11
    • Eating and obesity8
    • Medication and drug trials8

    Research settings

    • Student participant pools
    • Teaching a class
    • Clinical trials
    • US clinical research
    • Sites without internet
    Planning a study?
  • Methods

    • How evidence grades work
    • How test batteries work
    • How test order works
    Methods and questions

    Help

    • FAQ
    • Recruitment guides
    • Compare platforms

    Updates

    • Blog
    • New tests by email
    Latest post10 November 2026What you can do in ConductCognition todayA short tour of ConductCognition as it stands on 10 November. After this, we'll post when something changes how you run a study.Read the post
  • Pricing
Start Free
Log In
Log InStart Free
  1. Home
  2. /Data
  3. /Clinical trials
  4. /Tests
  5. /Sustained Attention to Response

Clinical trials data

Sustained Attention to Response in clinical trials: 85 registered studies

Every registered study on ClinicalTrials.gov that names Sustained Attention to Response in an outcome measure: the conditions it is used in, how often it is a primary outcome, the tests it is named with, and how large the studies are.

Registered studies name it in an outcome measure
85
Name it in a primary outcome, 46%
39 of 85
Against similar tests
Of studies started 2021 to 2025 name it, against 0.6% in 2016 to 2020
0.5%
By year
Median participants per study
74
By phase
Try Sustained Attention to Response

The conditions it is used in

Each study counted once in each condition group it falls in.
  1. Sleep and sleep disorders15 studies, 2 as a primary outcome

  2. Depression and bipolar disorder10 studies, 7 as a primary outcome

  3. Substance use and addiction10 studies, 0 as a primary outcome

  4. Anxiety, PTSD and OCD10 studies, 5 as a primary outcome

  5. Healthy volunteers7 studies, 4 as a primary outcome

  6. Brain injury and concussion5 studies, 5 as a primary outcome

  7. ADHD5 studies, 3 as a primary outcome

  8. Aging, frailty and exercise5 studies, 3 as a primary outcome

  9. Mild cognitive impairment4 studies, 0 as a primary outcome

  10. Parkinson's disease4 studies, 0 as a primary outcome

  11. Cardiovascular disease4 studies, 1 as a primary outcome

  12. Dementia and Alzheimer's3 studies, 1 as a primary outcome

  13. Stroke3 studies, 2 as a primary outcome

  14. Pain and fatigue3 studies, 1 as a primary outcome

  15. Multiple sclerosis1 study, 0 as a primary outcome

  16. Obesity and diabetes1 study, 0 as a primary outcome

  17. COVID-19 and long COVID1 study, 0 as a primary outcome

  18. Delirium, surgery and intensive care1 study, 0 as a primary outcome

  19. Other conditions16 studies, 13 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

How often it is a primary outcome

Sustained Attention to Response is a primary outcome in 46% of its studies. Across the 18 attention tests with a page here, the median is 41%.
  1. Eriksen Flanker Task53% of 334 studies

  2. Oddball Target Detection47% of 86 studies

  3. Sustained Attention to Response46% of 85 studies

  4. Dot-Probe Task43% of 148 studies

  5. Rapid Visual Information Processing42% of 204 studies

  6. Continuous Performance Test42% of 638 studies

  7. Attention Network Test41% of 138 studies

  8. Choice Reaction Time40% of 270 studies

  9. Cancellation Test40% of 253 studies

  10. Psychomotor Vigilance Task39% of 395 studies

  11. Contrast Sensitivity Test35% of 119 studies

  12. Line Angle Matching30% of 69 studies

Studies by start year

0.5% of the registered studies that started in 2021 to 2025 name it, against 0.6% of those that started in 2016 to 2020. 2026 is partly planned starts.
02000: 0 studies, 0 with a test as a primary outcome20002001: 1 studies, 0 with a test as a primary outcome2002: 1 studies, 0 with a test as a primary outcome2003: 0 studies, 0 with a test as a primary outcome2004: 0 studies, 0 with a test as a primary outcome2005: 0 studies, 0 with a test as a primary outcome20052006: 1 studies, 1 with a test as a primary outcome2007: 1 studies, 0 with a test as a primary outcome2008: 0 studies, 0 with a test as a primary outcome2009: 3 studies, 1 with a test as a primary outcome2010: 1 studies, 0 with a test as a primary outcome20102011: 1 studies, 1 with a test as a primary outcome2012: 1 studies, 0 with a test as a primary outcome2013: 4 studies, 1 with a test as a primary outcome2014: 3 studies, 1 with a test as a primary outcome2015: 2 studies, 1 with a test as a primary outcome20152016: 6 studies, 3 with a test as a primary outcome2017: 5 studies, 4 with a test as a primary outcome2018: 7 studies, 2 with a test as a primary outcome2019: 4 studies, 1 with a test as a primary outcome2020: 4 studies, 3 with a test as a primary outcome20202021: 6 studies, 1 with a test as a primary outcome2022: 9 studies, 5 with a test as a primary outcome2023: 4 studies, 3 with a test as a primary outcome2024: 7 studies, 5 with a test as a primary outcome2025: 11 studies, 5 with a test as a primary outcome20252026: 2 studies, 0 with a test as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Show as a table
Registered studies by start year
Start yearStudiesA test as a primary outcome
200000
200110
200210
200300
200400
200500
200611
200710
200800
200931
201010
201111
201210
201341
201431
201521
201663
201754
201872
201941
202043
202161
202295
202343
202475
2025115
202620

Phases and study sizes

By phase

  • Phase 11 studies, 0 as a primary outcome
  • Phase 25 studies, 2 as a primary outcome
  • Phase 2/31 studies, 0 as a primary outcome
  • Phase 35 studies, 0 as a primary outcome
  • Phase 43 studies, 0 as a primary outcome
  • Not applicable65 studies, 37 as a primary outcome
  • Observational5 studies, 0 as a primary outcome

Participants per study

102050100
  • Not applicable80 median, 42 to 108
Participants per study. The bar spans the middle half of the studies in each phase, the mark is the median, and the axis is logarithmic. Phases with fewer than 10 studies that give a size are left out.
Show as a table
Participants per study that names Sustained Attention to Response, by phase
PhaseStudies with a sizeMedianMiddle half
Not applicable638042 to 108

When trials measure it

Half of the primary outcomes that name Sustained Attention to Response are measured within 9 weeks of the start, and the middle half from 4 weeks to 4 months. 38 primary outcomes give a duration.

Latest time point of each outcome

  • Within a day8 outcomes, 3 as a primary outcome
  • Up to 4 weeks19 outcomes, 11 as a primary outcome
  • 1 to 3 months31 outcomes, 14 as a primary outcome
  • 3 to 6 months11 outcomes, 6 as a primary outcome
  • 6 to 12 months7 outcomes, 3 as a primary outcome
  • 1 to 2 years4 outcomes, 1 as a primary outcome
  • No duration given3 outcomes, 1 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

80 of the 83 outcome measures give a duration. A single visit counts as within a day.

Status, results, interventions and countries

Status

  • Recruiting16 studies, 7 as a primary outcome
  • Not yet recruiting1 studies, 1 as a primary outcome
  • Active, not recruiting1 studies, 1 as a primary outcome
  • Completed48 studies, 21 as a primary outcome
  • Stopped early10 studies, 5 as a primary outcome
  • Status unknown9 studies, 4 as a primary outcome

What they test

  • Behavioral43 studies, 27 as a primary outcome
  • Drug17 studies, 2 as a primary outcome
  • Device11 studies, 2 as a primary outcome
  • Dietary supplement5 studies, 3 as a primary outcome
  • Other16 studies, 10 as a primary outcome
  • None given3 studies, 0 as a primary outcome

Intervention types as registered. A study can list several; observational studies often list none.

Where their sites are

  • United States39 studies, 22 as a primary outcome
  • Canada9 studies, 4 as a primary outcome
  • Switzerland7 studies, 0 as a primary outcome
  • Ireland5 studies, 2 as a primary outcome
  • France4 studies, 2 as a primary outcome
  • Netherlands3 studies, 1 as a primary outcome
  • China2 studies, 0 as a primary outcome
  • Finland2 studies, 2 as a primary outcome
  • Germany2 studies, 1 as a primary outcome
  • Italy2 studies, 0 as a primary outcome
  • Spain2 studies, 0 as a primary outcome
  • Belgium1 studies, 0 as a primary outcome

17 countries in all. A study with sites in several counts in each; 3 list no site.

Reported results

Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.

Completed studies that name Sustained Attention to Response: 27 of 48, 56%

Every completed study with a cognitive outcome: 3,626 of 7,953, 46%

Completed studies that name Sustained Attention to Response and every completed study, by how they reported results
ResultsCompleted studies that name Sustained Attention to ResponseEvery completed study
Results on ClinicalTrials.gov and a paper3, 6%776, 10%
Results on ClinicalTrials.gov only6, 13%1,139, 14%
A results paper only18, 38%1,711, 22%
Neither21, 44%4,327, 54%

Tests named in the same studies

The library tests that studies naming Sustained Attention to Response name most often beside it.
  1. 1

    Go/No-Go Task25 studies, 9 as a primary outcome

  2. 2

    Stroop Color-Word Test10 studies, 3 as a primary outcome

  3. 3

    Verbal Learning9 studies, 4 as a primary outcome

  4. 4

    Trail Making Test9 studies, 2 as a primary outcome

  5. 5

    Digit Span Test8 studies, 5 as a primary outcome

  6. 6

    Symbol Coding8 studies, 4 as a primary outcome

  7. 7

    Psychomotor Vigilance Task8 studies, 3 as a primary outcome

  8. 8

    N-Back Task8 studies, 2 as a primary outcome

  9. 9

    Verbal Fluency8 studies, 2 as a primary outcome

  10. 10

    Paced Visual Serial Addition Test3 studies, 1 as a primary outcome

A test as a primary outcomeOnly in secondary or other outcomes

Compared over time

Studies per start year for Sustained Attention to Response and the tests named with it most. Add or remove tests to compare.
Sustained Attention to Response84 studies, 2000 to 2026
01002002000201020202026
Go/No-Go Task699 studies, 2000 to 2026
01002002000201020202026
Stroop Color-Word Test1,922 studies, 2000 to 2026
01002002000201020202026
Verbal Learning1,819 studies, 2000 to 2026
01002002000201020202026

The panel's testThe other tests chosenEvery panel has the same scale. 2026 is partly planned starts.

Show as a table
Registered studies per start year that name each test
Start yearSustained Attention to ResponseGo/No-Go TaskStroop Color-Word TestVerbal Learning
20000031
20011135
20021258
200301214
200402814
2005001117
200611613
2007111322
2008041528
2009351628
2010182942
20111133133
20121133242
20134194253
20143226482
20152246791
20166348598
201753779107
201874010392
2019446119122
20204329976
2021662151137
2022960168138
2023467198157
2024764182144
20251177198132
2026264193123

Explore the 85 studies

Filter by condition, phase, sponsor, status, country, intervention, outcome list, size and start year. Each study links to its record on ClinicalTrials.gov.
TestSustained Attention to Response

85 studies match. 39 name Sustained Attention to Response in a primary outcome. Median size 74 participants. Median time to the primary outcome: 9 weeks.

Loading 85 studies; the filters turn on when they arrive.

By start year
0510152000: 0 studies, 0 naming Sustained Attention to Response in a primary outcome20002001: 1 studies, 0 naming Sustained Attention to Response in a primary outcome2002: 1 studies, 0 naming Sustained Attention to Response in a primary outcome2003: 0 studies, 0 naming Sustained Attention to Response in a primary outcome2004: 0 studies, 0 naming Sustained Attention to Response in a primary outcome2005: 0 studies, 0 naming Sustained Attention to Response in a primary outcome20052006: 1 studies, 1 naming Sustained Attention to Response in a primary outcome2007: 1 studies, 0 naming Sustained Attention to Response in a primary outcome2008: 0 studies, 0 naming Sustained Attention to Response in a primary outcome2009: 3 studies, 1 naming Sustained Attention to Response in a primary outcome2010: 1 studies, 0 naming Sustained Attention to Response in a primary outcome20102011: 1 studies, 1 naming Sustained Attention to Response in a primary outcome2012: 1 studies, 0 naming Sustained Attention to Response in a primary outcome2013: 4 studies, 1 naming Sustained Attention to Response in a primary outcome2014: 3 studies, 1 naming Sustained Attention to Response in a primary outcome2015: 2 studies, 1 naming Sustained Attention to Response in a primary outcome20152016: 6 studies, 3 naming Sustained Attention to Response in a primary outcome2017: 5 studies, 4 naming Sustained Attention to Response in a primary outcome2018: 7 studies, 2 naming Sustained Attention to Response in a primary outcome2019: 4 studies, 1 naming Sustained Attention to Response in a primary outcome2020: 4 studies, 3 naming Sustained Attention to Response in a primary outcome20202021: 6 studies, 1 naming Sustained Attention to Response in a primary outcome2022: 9 studies, 5 naming Sustained Attention to Response in a primary outcome2023: 4 studies, 3 naming Sustained Attention to Response in a primary outcome2024: 7 studies, 5 naming Sustained Attention to Response in a primary outcome2025: 11 studies, 5 naming Sustained Attention to Response in a primary outcome20252026: 2 studies, 0 naming Sustained Attention to Response in a primary outcome

2026 is partly planned starts. Not shown: 1 planned to start after 2026.

Show as a table
Matching studies by start year
Start yearStudiesAs a primary outcome
200000
200110
200210
200300
200400
200500
200611
200710
200800
200931
201010
201111
201210
201341
201431
201521
201663
201754
201872
201941
202043
202161
202295
202343
202475
2025115
202620

Library tests named most

  • Sustained Attention to Response85 studies, 39 as a primary outcome
  • Go/No-Go Task25 studies, 9 as a primary outcome
  • Stroop Color-Word Test10 studies, 3 as a primary outcome
  • Verbal Learning9 studies, 4 as a primary outcome
  • Trail Making Test9 studies, 2 as a primary outcome
  • Digit Span Test8 studies, 5 as a primary outcome
  • Symbol Coding8 studies, 4 as a primary outcome
  • Psychomotor Vigilance Task8 studies, 3 as a primary outcome
  • N-Back Task8 studies, 2 as a primary outcome
  • Verbal Fluency8 studies, 2 as a primary outcome

Largest condition groups

Phases

Participants

Lead sponsor: industry 5, NIH 2, other 78. Interventional 80, observational 5.

As a primary outcomeSecondary or other outcomeSustained Attention to Response

The studies, newest registration first

Each number opens the study's record on ClinicalTrials.gov.

Registered studies that match the filters, newest registration first, with the library tests each one names and the outcome list that names them.
StudyStartPhaseConditionsParticipantsLead sponsorStatusLibrary tests named, with the latest time point
NCT07400432Start2025PhaseNot applicableConditionsAging, frailty and exerciseParticipants38Lead sponsorOtherStatusRecruitingLibrary tests named
  • Psychomotor Vigilance TaskPrimary
  • Sustained Attention to ResponsePrimary
NCT07389005Start2026PhaseNot applicableConditionsObesity and diabetesParticipants28Lead sponsorOtherStatusRecruitingLibrary tests named
  • Psychomotor Vigilance TaskOther outcomesame day
  • Sustained Attention to ResponseOther outcomesame day
NCT07355842Start2026PhaseNot applicableConditionsParkinson's disease, Sleep and sleep disordersParticipants80Lead sponsorOtherStatusRecruitingLibrary tests named
  • Trail Making TestSecondary18 months
  • Stroop Color-Word TestSecondary18 months
  • Verbal LearningSecondary18 months
  • Verbal FluencySecondary18 months
  • Digit Span TestSecondary18 months
  • Category FluencySecondary18 months
  • Picture Naming TestSecondary18 months
  • Psychomotor Vigilance TaskOther outcome18 months
  • Complex Figure Copy and RecallSecondary18 months
  • Finger Tapping TaskSecondary18 months
  • Sustained Attention to ResponseOther outcome18 months
  • Line Angle MatchingSecondary18 months
NCT07285954Start2025PhaseNot applicableConditionsOther conditionsParticipants90Lead sponsorOtherStatusRecruitingLibrary tests named
  • Stroop Color-Word TestPrimary6 months
  • Symbol CodingPrimary6 months
  • Card Sorting Test (Berg)Primary6 months
  • Sustained Attention to ResponsePrimary6 months
NCT07267845Start2025PhaseNot applicableConditionsHealthy volunteersParticipants80Lead sponsorOtherStatusRecruitingLibrary tests named
  • Stroop Color-Word TestPrimary6 weeks
  • Symbol CodingSecondary6 weeks
  • Go/No-Go TaskSecondary6 weeks
  • Sustained Attention to ResponseSecondary6 weeks
NCT07102953Start2025PhaseNot applicableConditionsOther conditionsParticipants112Lead sponsorOtherStatusCompletedLibrary tests named
  • Sustained Attention to ResponseSecondary1 week
  • Alternative Uses TaskPrimary4 weeks
NCT07085819Start2025PhaseNot applicableConditionsSleep and sleep disordersParticipants160Lead sponsorIndustryStatusRecruitingLibrary tests named
  • Rapid Visual Information ProcessingSecondary8 weeks
  • Sustained Attention to ResponseSecondary8 weeks
NCT07074639Start2025PhaseNot applicableConditionsAging, frailty and exerciseParticipants344Lead sponsorOtherStatusRecruitingLibrary tests named
  • Go/No-Go TaskSecondary12 weeks
  • Choice Reaction TimeSecondary12 weeks
  • Simple Reaction TimeSecondary12 weeks
  • Sustained Attention to ResponseSecondary12 weeks
NCT07056634Start2025PhaseNot applicableConditionsOther conditionsParticipants69Lead sponsorOtherStatusCompletedLibrary tests named
  • Digit Span TestPrimary4 weeks
  • Sustained Attention to ResponsePrimary4 weeks
  • Alternative Uses TaskSecondary4 weeks
NCT07001930Start2025PhasePhase 1ConditionsSubstance use and addictionParticipants90Lead sponsorOtherStatusRecruitingLibrary tests named
  • N-Back TaskSecondarysame day
  • Purchase TaskSecondarysame day
  • Sustained Attention to ResponseSecondarysame day
NCT06976879Start2024PhaseObservationalConditionsHealthy volunteersParticipants60Lead sponsorOtherStatusRecruitingLibrary tests named
  • N-Back TaskSecondary
  • Eriksen Flanker TaskSecondary
  • Sustained Attention to ResponseSecondary
NCT06804304Start2025PhaseNot applicableConditionsStroke, Depression and bipolar disorder, Anxiety, PTSD and OCDParticipants100Lead sponsorOtherStatusRecruitingLibrary tests named
  • Verbal FluencyPrimary13 weeks
  • Digit Span TestPrimary13 weeks
  • Short Story RecallSecondary6 months
  • Cancellation TestSecondary6 months
  • Sustained Attention to ResponsePrimary13 weeks
  • Simon TaskPrimary13 weeks
NCT06798324Start2025PhasePhase 4ConditionsSubstance use and addictionParticipants160Lead sponsorOtherStatusRecruitingLibrary tests named
  • N-Back TaskSecondary12 months
  • Stop-Signal TaskSecondary12 months
  • Sustained Attention to ResponseSecondary12 months
NCT06711406Start2024PhaseObservationalConditionsADHDParticipants50Lead sponsorOtherStatusCompletedLibrary tests named
  • Sustained Attention to ResponseSecondarysame day
NCT06710678Start2024PhaseNot applicableConditionsOther conditionsParticipants120Lead sponsorOtherStatusRecruitingLibrary tests named
  • Stroop Color-Word TestSecondarysame day
  • Go/No-Go TaskPrimarysame day
  • Sustained Attention to ResponsePrimarysame day
NCT06667193Start2024PhaseNot applicableConditionsOther conditionsParticipants36Lead sponsorOtherStatusCompletedLibrary tests named
  • Sustained Attention to ResponsePrimary4 weeks
NCT06619795Start2018PhaseNot applicableConditionsDementia and Alzheimer'sParticipants23Lead sponsorOtherStatusStopped early

Paper

Library tests named
  • Verbal FluencySecondary2 weeks
  • Digit Span TestSecondary2 weeks
  • Sustained Attention to ResponseSecondary2 weeks
NCT06582927Start2025PhaseNot applicableConditionsOther conditionsParticipants87Lead sponsorOtherStatusCompletedLibrary tests named
  • Sustained Attention to ResponsePrimary11 weeks
NCT06536530Start2027PhaseNot applicableConditionsDepression and bipolar disorderParticipants150Lead sponsorOtherStatusNot yet recruitingLibrary tests named
  • Card Sorting Test (Berg)Primary8 weeks
  • Sustained Attention to ResponsePrimary8 weeks
  • Visual Search TestPrimary8 weeks
NCT06270862Start2024PhaseNot applicableConditionsHealthy volunteers, Aging, frailty and exerciseParticipants240Lead sponsorOtherStatusStatus unknownLibrary tests named
  • Stroop Color-Word TestPrimary4 weeks
  • Sustained Attention to ResponsePrimary4 weeks
NCT06267521Start2024PhaseNot applicableConditionsOther conditionsParticipants64Lead sponsorOtherStatusCompleted

Paper

Library tests named
  • Psychomotor Vigilance TaskPrimary4 weeks
  • Implicit Association Test (IAT)Primary5 weeks
  • Sustained Attention to ResponsePrimary5 months
  • Emotional Stroop TaskPrimary5 weeks
  • Probabilistic Reversal LearningPrimary5 weeks
  • Multi-Source Interference TaskPrimary5 weeks
NCT06145984Start2020PhaseNot applicableConditionsDepression and bipolar disorderParticipants100Lead sponsorOtherStatusRecruitingLibrary tests named
  • Go/No-Go TaskPrimarysame day
  • Sustained Attention to ResponsePrimarysame day
NCT06115603Start2024PhasePhase 2ConditionsADHDParticipants67Lead sponsorOtherStatusCompletedLibrary tests named
  • Trail Making TestPrimarysame day
  • Verbal LearningPrimarysame day
  • Symbol CodingPrimarysame day
  • Iowa Gambling LitePrimarysame day
  • Sustained Attention to ResponsePrimarysame day
NCT06114017Start2023PhaseNot applicableConditionsOther conditionsParticipants50Lead sponsorOtherStatusStatus unknownLibrary tests named
  • Stroop Color-Word TestSecondary1 week
  • Sustained Attention to ResponsePrimary1 week
NCT06076967Start2023PhaseNot applicableConditionsADHDParticipants100Lead sponsorOtherStatusStatus unknownLibrary tests named
  • Attention Network TestPrimary6 months
  • Sustained Attention to ResponsePrimary6 months

Page 1 of 4

Questions, answered from the data

How many clinical trials use Sustained Attention to Response?

85 registered studies on ClinicalTrials.gov name it in an outcome measure, 39 of them in a primary outcome.

In which conditions do trials use Sustained Attention to Response?

Most often in sleep and sleep disorders (15), depression and bipolar disorder (10) and substance use and addiction (10).

Do new trials use Sustained Attention to Response more or less?

0.5% of the studies that started in 2021 to 2025 name it, against 0.6% of those that started in 2016 to 2020: a share 10% smaller.

Which tests do trials use with Sustained Attention to Response?

The Go/No-Go Task (25 studies), the Stroop Color-Word Test (10 studies) and Verbal Learning (9 studies).

When do trials measure Sustained Attention to Response?

Half of the primary outcomes that name Sustained Attention to Response are measured within 9 weeks of the start, and the middle half from 4 weeks to 4 months. 38 primary outcomes give a duration.

How many completed trials that use Sustained Attention to Response have reported results?

27 of the 48 completed studies that name it, 56%, have reported results: 9 posted them on ClinicalTrials.gov, 21 have a results paper linked to the registry record, and 3 did both. The other 21 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.

More on tests in clinical trials

  • Sustained Attention to Response: what it measures, its scores, and a version to try
  • All 101 tests in clinical trials
  • Cognitive tests by condition
  • Every registered study, by test, condition, phase and year

How the studies are counted

For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.

The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.

A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.

A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.

Run Sustained Attention to Response in your trial

Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.

Start free
ConductCognition

Hosted browser-native cognitive testing for academic and commercial research workflows.

A product of ConductScience, Inc.

New tests and features, about once a month. Unsubscribe at any time.

Tests

  • All cognitive tests
  • Test batteries
  • Use and evidence
  • Test norms
  • Trail Making Test
  • N-Back Task
  • Automated scoring
  • Study design
  • New tests by email

Guides

  • Methods and questions
  • Blog
  • Recruitment setup
  • Participant devices
  • Prolific
  • Sona Systems
  • CloudResearch Connect
  • Qualtrics

Use cases

  • Student participant pools
  • Aging and dementia research
  • Clinical trials
  • US clinical research
  • Remote testing

Compare and buy

  • Pricing
  • Compare platforms
  • Offline edition
  • FAQ

Trust

  • Study Quality Monitor
  • HIPAA-ready testing
  • Data export
  • Privacy Policy
  • Terms of Use
  • Data Policy

Company

  • ConductScience
  • Affiliate Program
© 2026 ConductScience, Inc. Research use only.